Bass, Berry & Sims was named a finalist in two categories for the M&A Atlas Awards, Middle Markets. The M&A Atlas Awards, Middle Markets – produced by Global M&A Network – recognizes the top deals and firms from the past year. The winners will be announced at a gala held on March 5 in Washington, D.C.

The firm was recognized in the following categories:

  • Outstanding Firm Award – Middle Market M&A Law: Healthcare: Bass, Berry & Sims was named a finalist in this category along with McDermott Will & Emery and Pepper Hamilton.
  • Deal of the Year Award – USA Investments & Acquisitions Deals: Growth Deal (200-500mm) – General Atlantic Investment in OneOncology. The firm was recognized as a finalist related to our representation of Tennessee Oncology in the launch of OneOncology in affiliation with global private equity firm General Atlantic. Read more about that transaction here.

More information about the M&A Atlas Awards, Middle Market can be found here.

About the Healthcare Practice at Bass, Berry & Sims
Marked by an integrated approach and unmatched healthcare regulatory knowledge, the Healthcare Practice of Bass, Berry & Sims is a team of more than 200 experienced healthcare attorneys who leverage their diverse strengths to meet the unique demands of our clients. Because of this depth, the firm is ranked as the fourth largest healthcare law firm in the U.S. by American Health Lawyers Association (2019). We provide healthcare regulatory counsel to 25 publicly traded healthcare companies and more than 200 businesses in the healthcare industry located throughout the United States. We have extensive experience in representing investors, lenders and investment banking firms in financing transactions for healthcare companies. Our team has advised on more than $117 billion in healthcare transactions and more than $52 billion in debt and equity offerings. Read more about the practice here.